The close monitoring of HIV drug resistance using genotypic HIV drug resistance testing (HIVDRT) has become essential for effective HIV/AIDS management at both individual and population levels. Over the years, a broad spectrum of analytes or specimens have been applied or attempted in HIVDRT; however, the suitability and performance of these analytes in HIVDRT and the clinical relevance of the results from them may vary significantly. This article provides a focused overview of the performance, strengths, and weaknesses of various analytes while used in HIVDRT, which may inform the optimal analytes selection in different application contexts.
CITATION STYLE
Ji, H., & Sandstrom, P. (2022, July 1). Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing. Pathogens. MDPI. https://doi.org/10.3390/pathogens11070739
Mendeley helps you to discover research relevant for your work.